dalbavancine
J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01X - Other Antibacterials -> J01XA - Glycopeptide Antibacterials -> J01XA04 - Dalbavancin
Administration category:
Limited
Medicine group:
antibacterial
Brand name:
Xydalba
Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
|
ROA: iv |
Load: - |
Dosage: 1500mg |
||
|
Comments:
1500 mg als enkelvoudige infusie. Toedienen in 30 min (opgelost in glucose 5%). Evt. herhalen na 2 weken |
||||
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: iv | ||||
|
GFR: <30 |
Comments: 1000 mg als enkelvoudige infusie, of 750 mg + na 1 week 375 mg |
|||
Renal function-replacement therapy
CAPD: gebruik vermijden vanwege het ontbreken van gegevens
Hemo dialysis: 1000 mg als enkelvoudige infusie, of 750 mg + na 1 week 375 mg
CAV / VVHD: 1000 mg als enkelvoudige infusie, of 750 mg + na 1 week 375 mg
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-502500.1
Updated: 10/30/2024 - 15:57
Status: Published